Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELTROMBOPAG OLAMINE Cause Product prescribing issue? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product prescribing issue have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.0% of all adverse event reports for ELTROMBOPAG OLAMINE.

5
Reports of Product prescribing issue with ELTROMBOPAG OLAMINE
0.0%
of all ELTROMBOPAG OLAMINE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product prescribing issue From ELTROMBOPAG OLAMINE?

Of the 5 reports, 2 (40.0%) required hospitalization.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?

Platelet count decreased (3,419) Death (2,797) Drug ineffective (1,117) Platelet count increased (980) Fatigue (868) Headache (750) Nausea (584) Diarrhoea (558) Product use in unapproved indication (545) Malaise (516)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which ELTROMBOPAG OLAMINE Alternatives Have Lower Product prescribing issue Risk?

ELTROMBOPAG OLAMINE vs ELUXADOLINE ELTROMBOPAG OLAMINE vs ELVITEGRAVIR ELTROMBOPAG OLAMINE vs EMAPALUMAB ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG ELTROMBOPAG OLAMINE vs EMEND

Related Pages

ELTROMBOPAG OLAMINE Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue ELTROMBOPAG OLAMINE Demographics